Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
NCT ID: NCT02809651
Last Updated: 2017-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2016-08-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)
NCT05276934
Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.
NCT05589103
Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients
NCT07100132
Assessment of Intracerebral Hematoma
NCT05158660
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
NCT01689402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the investigators prospectively want to use the Infrascanner in patients with ischemic stroke, patients with brain surgery, patients with brain tumors, patients with intracranial hemorrhage and patients with a normal CT scan of the brain as part of a diagnostic work-up after head trauma or headache to determine the positive and negative predictive value of the Infrascanner in these different settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic stroke
patients suffering from ischemic stroke diagnosed by clinical examination and CT-scan
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Brain tumor
patients diagnosed with a brain tumor diagnosed by clinical examination and CT-scan or MRI
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Brain surgery
patients that have undergone brain surgery
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Intracranial hemorrhage
patients with intracranial hemorrhage diagnosed by clinical examination and CT-scan
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Headache
patients with headache complaints and a normal CT-scan of the brain
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Headtrauma
patients with head trauma and a normal CT-scan of the brain
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infrascanner
bilateral measurement cerebral blood flow with near infrared spectroscopy using the Infrascanner on the frontal, temporal, parietal and occipital region of the head.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a brain tumor diagnosed by clinical examination and CT-scan or MRI
* Patients with an intracranial hemorrhage diagnosed by clinical examination and CT-scan
* Patients that have undergone brain surgery
* Patients with a normal CT-scan of the brain after head trauma
* Patients with headache complaints and a normal CT-scan of the brain as part of their diagnostic work-up
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pascal Vanelderen
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal Vanelderen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
member of Staff
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/015U
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.